HK1173722A1 - Crystal of substituted phenylalkanoic acid and production process - Google Patents

Crystal of substituted phenylalkanoic acid and production process

Info

Publication number
HK1173722A1
HK1173722A1 HK13100299.3A HK13100299A HK1173722A1 HK 1173722 A1 HK1173722 A1 HK 1173722A1 HK 13100299 A HK13100299 A HK 13100299A HK 1173722 A1 HK1173722 A1 HK 1173722A1
Authority
HK
Hong Kong
Prior art keywords
crystal
production process
phenylalkanoic acid
substituted phenylalkanoic
substituted
Prior art date
Application number
HK13100299.3A
Other languages
English (en)
Chinese (zh)
Inventor
有本雄
石井尚之
正田基
Original Assignee
旭化成制藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 旭化成制藥株式會社 filed Critical 旭化成制藥株式會社
Publication of HK1173722A1 publication Critical patent/HK1173722A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK13100299.3A 2006-07-20 2013-01-09 Crystal of substituted phenylalkanoic acid and production process HK1173722A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006197637 2006-07-20

Publications (1)

Publication Number Publication Date
HK1173722A1 true HK1173722A1 (en) 2013-05-24

Family

ID=38956781

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09110023.1A HK1130060A1 (en) 2006-07-20 2009-10-28 Novel crystal of substituted phenylalkanoic acid and production process
HK13100299.3A HK1173722A1 (en) 2006-07-20 2013-01-09 Crystal of substituted phenylalkanoic acid and production process

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09110023.1A HK1130060A1 (en) 2006-07-20 2009-10-28 Novel crystal of substituted phenylalkanoic acid and production process

Country Status (13)

Country Link
US (4) US7560478B2 (xx)
EP (2) EP2045244B1 (xx)
JP (2) JP5137834B2 (xx)
KR (3) KR20120084790A (xx)
CN (2) CN101490012B (xx)
AU (2) AU2007274477B2 (xx)
CA (3) CA2659471C (xx)
DK (1) DK2045244T3 (xx)
ES (1) ES2402782T3 (xx)
HK (2) HK1130060A1 (xx)
MX (1) MX2009000448A (xx)
PT (1) PT2045244E (xx)
WO (1) WO2008010448A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009205073B2 (en) 2008-01-18 2012-04-12 Asahi Kasei Pharma Corporation Stable pharmaceutical composition
JP5198560B2 (ja) * 2008-04-28 2013-05-15 旭化成ファーマ株式会社 フェニルプロピオン酸誘導体及びその用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0495025A (ja) 1990-08-08 1992-03-27 Asahi Chem Ind Co Ltd アルドースリダクターゼ阻害剤
JPH0495049A (ja) 1990-08-08 1992-03-27 Asahi Chem Ind Co Ltd ビフェニル‐5,5’‐ビス‐アルカン酸誘導体、その製造法およびその用途
CN1103332C (zh) 1997-10-14 2003-03-19 旭化成株式会社 联苯基-5-链烷羧酸衍生物和其应用
SI1323701T1 (sl) 2000-09-07 2009-12-31 Kaneka Corp Postopki za kristalizacijo hidroksikarboksilnih kislin
AU2002331885B2 (en) * 2001-09-26 2007-07-26 Merck & Co., Inc. Crystalline forms of ertapenem sodium
ITRM20020016A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
US6867320B2 (en) * 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
KR100938950B1 (ko) 2002-02-21 2010-01-26 아사히 가세이 파마 가부시키가이샤 치환 페닐 알칸산 유도체 및 그 용도
CA2535665A1 (en) * 2003-08-14 2005-02-24 Asahi Kasei Pharma Corporation Substituted arylalkanoic acid derivative and use thereof
DE102006023178A1 (de) * 2005-05-18 2006-12-28 Chemagis Ltd. Verbesserte Verfahren zum Herstellen von hoch reinem Telmisartan Form A, das für pharmazeutische Zusammensetzungen geeignet ist

Also Published As

Publication number Publication date
DK2045244T3 (da) 2013-04-15
AU2007274477A1 (en) 2008-01-24
US7560478B2 (en) 2009-07-14
KR101322116B1 (ko) 2013-10-25
EP2045244A4 (en) 2010-09-08
KR20120084790A (ko) 2012-07-30
PT2045244E (pt) 2013-04-15
US7935720B2 (en) 2011-05-03
CN102690234A (zh) 2012-09-26
US7838546B2 (en) 2010-11-23
CA2820931A1 (en) 2008-01-24
JP2013028638A (ja) 2013-02-07
CA2773177C (en) 2013-09-24
KR101440255B1 (ko) 2014-09-17
US20080070967A1 (en) 2008-03-20
WO2008010448A1 (fr) 2008-01-24
JP5137834B2 (ja) 2013-02-06
AU2007274477B2 (en) 2010-11-25
CA2773177A1 (en) 2008-01-24
EP2620431A1 (en) 2013-07-31
EP2045244A1 (en) 2009-04-08
US7754752B2 (en) 2010-07-13
EP2045244B1 (en) 2013-04-03
CN101490012B (zh) 2012-07-18
US20090312386A1 (en) 2009-12-17
CN102690234B (zh) 2014-12-24
KR20130108487A (ko) 2013-10-02
CA2659471A1 (en) 2008-01-24
MX2009000448A (es) 2009-01-27
US20100234440A1 (en) 2010-09-16
CN101490012A (zh) 2009-07-22
US20110021593A1 (en) 2011-01-27
JPWO2008010448A1 (ja) 2009-12-17
AU2011200408A1 (en) 2011-02-24
ES2402782T8 (es) 2013-06-10
AU2011200408B2 (en) 2011-05-26
HK1130060A1 (en) 2009-12-18
KR20080104063A (ko) 2008-11-28
JP5550696B2 (ja) 2014-07-16
ES2402782T3 (es) 2013-05-08
CA2659471C (en) 2012-06-12
CA2820931C (en) 2015-08-18

Similar Documents

Publication Publication Date Title
HK1137486A1 (en) Microbiological production of 3-hydroxyisobutyric acid
EP2100957A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP2088153A4 (en) GLUTATHIONIC CRYSTAL AND METHOD FOR THE PRODUCTION THEREOF
ZA200709028B (en) Process for the production of acetic acid
EP2090609A4 (en) METHOD FOR PRODUCING A POLYAMIDE ACID SOLUTION AND POLYAMIDE ACID SOLUTION
EP2003209A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
PL1784378T3 (pl) Sposób wytwarzania surowego kwasu tereftalowego
EP2083083A4 (en) PROCESS FOR PRODUCING L-AMINO ACID
EP2093210A4 (en) PROCESS FOR THE PREPARATION OF TEREPHTHALIC ACID
EP2070684A4 (en) METHOD FOR PRODUCING A POLYMILIC ACID FILM
LT1989165T (lt) Karboksirūgšties gamybos būdas
EP2100872A4 (en) PROCESS FOR PRODUCTION OF ACRYLIC ACID, APPARATUS FOR PRODUCTION OF ACRYLIC ACID, AND COMPOSITION FOR THE PRODUCTION OF ACRYLIC ACID
EP2067770A4 (en) PROCESS FOR THE PREPARATION OF SULPHONIC ACID ESTERS
PL2080808T3 (pl) Sposób wytwarzania l-aminokwasu
EP1914220A4 (en) PROCESS FOR THE PREPARATION OF 2-HYDROXYESTERS
EP1990416A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP2133356A4 (en) METHOD FOR PRODUCING A PHOSPHORUS-CONTAINING KETOSIC ACID
PT2079843T (pt) Processo para a produção de biogás
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
IL194938A0 (en) Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof
ZA200905851B (en) Method for the production of acrylic acid
EP2093211A4 (en) PROCESS FOR PRODUCTION OF ISOPHTHALIC ACID
IL196642A0 (en) Process for production of optically active aminophosphinylbutanoic acid
EP2072622A4 (en) PROCESS FOR PRODUCTION OF L-AMINO ACID
EP2083035A4 (en) PROCESS FOR PREPARING POLYESTER

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190715